Ophthalmology Department, University of Ioannina, Ioannina, Greece.
J Crohns Colitis. 2013 Oct;7(9):683-93. doi: 10.1016/j.crohns.2012.09.020. Epub 2012 Oct 18.
BACKGROUND AND AIMS: Extraintestinal manifestations of inflammatory bowel disease (IBD) can involve the orbit and the optic nerve. Although these manifestations are rare, they can be particularly serious as they can lead to permanent loss of vision. The aim of the review is to present the existing literature on IBD-related optic nerve and orbital complications. METHODS: A literature search identified the publications reporting on incidence, clinical features and management of IBD patients with optic nerve and orbital manifestations. RESULTS: Posterior scleritis and orbital inflammatory disease (orbital pseudotumor) are the most commonly encountered entities affecting the structures of the orbit. On the other hand, the optic nerve of IBD patients can be affected by conditions such as optic (demyelinating) neuritis ("retrobulbar" neuritis), or ischaemic optic neuropathy. Other neuro-ophthalmic manifestations that can be encountered in patients with IBD are related to increased intracranial pressure or toxicity secondary to anti tumour necrosis factor (anti-TNF) agents. CONCLUSIONS: IBD-related optic nerve and orbital complications are rare but potentially vision-threatening. Heightened awareness and close cooperation between gastroenterologists and ophthalmologists are warranted.
背景与目的:炎症性肠病(IBD)的肠外表现可累及眼眶和视神经。尽管这些表现较为罕见,但可能特别严重,因为它们可导致永久性视力丧失。本综述旨在介绍有关与 IBD 相关的视神经和眼眶并发症的现有文献。
方法:通过文献检索,确定了报道 IBD 患者视神经和眼眶表现的发生率、临床特征和治疗方法的出版物。
结果:后部巩膜炎和眼眶炎性疾病(眼眶假瘤)是最常发生的影响眼眶结构的疾病。另一方面,IBD 患者的视神经可受到诸如视神经(脱髓鞘)炎(“球后”神经炎)或缺血性视神经病变等疾病的影响。在 IBD 患者中还可遇到与颅内压升高或抗肿瘤坏死因子(抗 TNF)药物毒性相关的其他神经眼科表现。
结论:与 IBD 相关的视神经和眼眶并发症较为罕见,但可能威胁视力。因此,需要提高对这些并发症的认识,并加强胃肠病学家和眼科医生之间的合作。
J Crohns Colitis. 2012-10-18
J Crohns Colitis. 2011-11-13
Inflamm Bowel Dis. 2007-11
Expert Opin Drug Saf. 2008-9
J Crohns Colitis. 2013-3-1
Int J Environ Res Public Health. 2022-11-25
BMC Neurol. 2022-11-2
BMJ Open Ophthalmol. 2022-6
Case Rep Ophthalmol. 2022-6-17
Front Med (Lausanne). 2021-9-28